patient-derived models, Metastasis, & Resistance
Patient-derived xenograft models
Patient-derived xenograft models
What are the genes responsible for the succssful engraftment in breast cancer PDX models? (Breast Cancer Res Treat, 2015)
PDX models for malignant phyllodes tumors reveals potential targeted therapeutic approaches. (Br J Cancer, 2023)
CX3CR1-positive immune cells in pre-metastatic niche formation for TNBC liver metastasis. (Mol Cancer Res, 2023)
Novel targets for resistance and recurrences
Novel targets for resistance and recurrences
PDX model identifies PPM1H and CDK signaling associated with drug resistance. (J Breast Cancer, 2020)
JAK2 mediates paclitaxel resistance via microenvironment remodeling (J Mol Med, 2021)
Polo-like kinase 1 regulates chromosomal instability and paclitaxel resistance in breast cancer cells (J Breast Cancer, 2022)
AKR1C2 in TNBC may regulate the LAR subtype phenotype in TNBC (J Breast Cancer, 2023)